Johns Hopkins Medicine: Novel Machine Learning Blood Test Detects Cancers With Genome-Wide Mutations in Single Molecules of Cell-Free DNA
July 27, 2023
July 27, 2023
BALTIMORE, Maryland, July 27 -- Johns Hopkins Medicine issued the following news release:
Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and other cancers.
The test, called GEMINI (Genome-wide Mutational Incidence for Non-Invasive detection of cancer), looks for changes to DNA t . . .
Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and other cancers.
The test, called GEMINI (Genome-wide Mutational Incidence for Non-Invasive detection of cancer), looks for changes to DNA t . . .